Benefit of combination chemotherapy and radiation stratified by grade of stage IIIC endometrial cancer
- 1 November 2017
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 147 (2) , 309-314
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancerGynecologic Oncology, 2013
- Combined chemotherapy and radiation improves survival for node-positive endometrial cancerGynecologic Oncology, 2012
- Sequential chemotherapy and radiotherapy as sandwich therapy for the treatment of high risk endometrial cancerJournal of Gynecologic Oncology, 2012
- A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group studyGynecologic Oncology, 2009
- The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancerGynecologic Oncology, 2007
- Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2006
- Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III–IV endometrial cancer patientsGynecologic Oncology, 2004
- Nodal Distribution and Its Significance in FIGO Stage IIIc Endometrial CancerGynecologic Oncology, 2001
- Survival in patients with paraaortic lymph node metastases from endometrial adenocarcinoma clinically limited to the uterusInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1993
- Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group studyGynecologic Oncology, 1991